Table 1.
Characteristics of the Study Participants by Treatment Group
| Variable | Treatment Group | P Value | |
|---|---|---|---|
| SMBG | RT-CGM | ||
| (n = 50) | (n = 50) | ||
| Age [mean (SD)]a | 60.0 (11.9) | 55.5 (9.6) | 0.04 |
| Male (n)b | 22/50 | 33/50 | 0.03 |
| Therapyb | 0.76 | ||
| Diet and exercise only (n) | 4/50 | 3/50 | |
| Oral medications only (n) | 27/50 | 24/50 | |
| Oral medications/Byetta (n) | 5/50 | 4/50 | |
| Basal insulin, alone or in combination (n) | 14/50 | 19/50 | |
| Body mass index—baseline [mean (SD)] | 32.7 (7.7) | 31.9 (5.8) | 0.54 |
| Weight at baseline [mean (SD)]a | 197.3 (46.4) | 206.5 (35.7) | 0.27 |
| Weight at 12 weeks [mean (SD)]a | 196.5 (43.1) | 202.6 (32.3) | 0.42 |
| Systolic BP at baseline [mean (SD)]a | 132.5 (19.3) | 130.8 (16.2) | 0.46 |
| Systolic BP at 12 weeks [mean (SD)]a | 129.5 (18.0) | 129.3 (16.7) | 0.95 |
| Diastolic BP at baseline [mean (SD)]a | 77.6 (9.8) | 79.0 (8.9) | 0.46 |
| Diastolic BP at 12 weeks [mean (SD)]a | 76.2 (8.3) | 77.7 (11.3) | 0.46 |
| A1C at baseline [mean (SD)]a | 8.2 (1.1) | 8.4 (1.3) | 0.24 |
| A1C at 12 weeks [mean (SD)]a | 7.7 (1.2) | 7.4 (1.0) | 0.23 |
a
P value is from a t-test.
b
P value is from a chi-square test.